ADVISORY/DRAXIMAGE to Present Infection Imaging Data at EANM 2003 Annual Congress.Business Editors/Health/Medical Writers ADVISORY... MISSISSAUGUA, Ontario--(BUSINESS WIRE)--Aug. 22, 2003 DRAXIMAGE, Inc., the radiopharmaceutical radiopharmaceutical /ra·dio·phar·ma·ceu·ti·cal/ (-fahr?mah-soo´ti-k'l) a radioactive pharmaceutical, nuclide, or other chemical used for diagnostic or therapeutic purposes. division of the Canadian-based specialty pharmaceutical company DRAXIS Health Inc. (Nasdaq: DRAX)(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension : DAX)(www.draxis.com), will present a poster on Infection Imaging at the European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. Association of Nuclear Medicine (EANM EANM European Association of Nuclear Medicine 2003) Annual Congress in Amsterdam, August 23-27. The DRAXIMAGE poster presentation, titled "The Effect of Dilution Dilution A reduction in earnings per share of common stock that occurs through the issuance of additional shares or the conversion of convertible securities. Notes: Adding to the number of shares outstanding reduces the value of holdings of existing shareholders. of Reconstituted INFECTON(R) on Whole Body Biodistribution and Uptake uptake /up·take/ (up´tak) absorption and incorporation of a substance by living tissue. up·take n. at Site of Infection in the Rat," will be on display from August 24 to August 26, 2003 at the EANM 2003 Annual Congress. DRAXIMAGE is currently developing 99m Tc-ciprofloxacin (INFECTON(R)) as an infection imaging agent. The focus of this investigation is to determine any differences in liver uptake levels that might be apparent between clinical and rodent rodent, member of the mammalian order Rodentia, characterized by front teeth adapted for gnawing and cheek teeth adapted for chewing. The Rodentia is by far the largest mammalian order; nearly half of all mammal species are rodents. studies. Dr. George Desypris, Director of Clinical Research at DRAXIMAGE, will present this poster at EANM 2003. In addition, Dr. Richard Flanagan, President of DRAXIMAGE will also be available to discuss the Company's comprehensive portfolio of diagnostic and therapeutic products, as well as DRAXIMAGE's scientific and business direction in Europe. Media interested in meeting with Dr. Flanagan may contact him directly at EANM 2003 or reach the company's PR representative, Paul Kidwell after the meeting: 617-296-3854, paul_kidwell@hotmail.com.
WHO: Dr. Richard Flanagan, President
Dr. George Desypris, Director of Clinical Development
DRAXIMAGE, Inc.
www.draximage.com
WHAT: EANM Scientific Poster Presentation
"The Effect of Dilution of Reconstituted INFECTON(TM)
on Whole Body Biodistribution and Uptake at Site of
Infection in the Rat"
WHERE: EANM 2003 Annual Meeting Congress
POSTER DISPLAY: August 24 to August 26, 2003
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion